Purifying Selection Determines the Short-Term Time Dependency of Evolutionary Rates in SARS-CoV-2 and pH1N1 Influenza.


Journal

Molecular biology and evolution
ISSN: 1537-1719
Titre abrégé: Mol Biol Evol
Pays: United States
ID NLM: 8501455

Informations de publication

Date de publication:
03 02 2022
Historique:
pubmed: 18 1 2022
medline: 15 2 2022
entrez: 17 1 2022
Statut: ppublish

Résumé

High-throughput sequencing enables rapid genome sequencing during infectious disease outbreaks and provides an opportunity to quantify the evolutionary dynamics of pathogens in near real-time. One difficulty of undertaking evolutionary analyses over short timescales is the dependency of the inferred evolutionary parameters on the timespan of observation. Crucially, there are an increasing number of molecular clock analyses using external evolutionary rate priors to infer evolutionary parameters. However, it is not clear which rate prior is appropriate for a given time window of observation due to the time-dependent nature of evolutionary rate estimates. Here, we characterize the molecular evolutionary dynamics of SARS-CoV-2 and 2009 pandemic H1N1 (pH1N1) influenza during the first 12 months of their respective pandemics. We use Bayesian phylogenetic methods to estimate the dates of emergence, evolutionary rates, and growth rates of SARS-CoV-2 and pH1N1 over time and investigate how varying sampling window and data set sizes affect the accuracy of parameter estimation. We further use a generalized McDonald-Kreitman test to estimate the number of segregating nonneutral sites over time. We find that the inferred evolutionary parameters for both pandemics are time dependent, and that the inferred rates of SARS-CoV-2 and pH1N1 decline by ∼50% and ∼100%, respectively, over the course of 1 year. After at least 4 months since the start of sequence sampling, inferred growth rates and emergence dates remain relatively stable and can be inferred reliably using a logistic growth coalescent model. We show that the time dependency of the mean substitution rate is due to elevated substitution rates at terminal branches which are 2-4 times higher than those of internal branches for both viruses. The elevated rate at terminal branches is strongly correlated with an increasing number of segregating nonneutral sites, demonstrating the role of purifying selection in generating the time dependency of evolutionary parameters during pandemics.

Identifiants

pubmed: 35038728
pii: 6509523
doi: 10.1093/molbev/msac009
pmc: PMC8826518
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.

Références

Mol Biol Evol. 2000 Jul;17(7):1081-90
pubmed: 10889221
Science. 2014 Sep 12;345(6202):1369-72
pubmed: 25214632
Biol Lett. 2013 Jul 24;9(5):20130331
pubmed: 23883574
PLoS Curr. 2009 Aug 18;1:RRN1003
pubmed: 20025195
BMC Biol. 2010 Aug 31;8:114
pubmed: 20807414
Mol Biol Evol. 2011 Dec;28(12):3355-65
pubmed: 21705379
Nat Commun. 2015 Aug 06;6:7952
pubmed: 26245473
J Theor Biol. 2006 Mar 21;239(2):226-35
pubmed: 16239014
Virus Evol. 2020 Aug 19;6(2):veaa061
pubmed: 33235813
Gene. 2007 Dec 1;404(1-2):117-25
pubmed: 17928171
Curr Biol. 2021 Nov 8;31(21):4689-4696.e5
pubmed: 34478645
Nature. 2009 Jun 25;459(7250):1122-5
pubmed: 19516283
Syst Biol. 2016 Mar;65(2):250-64
pubmed: 26526428
Elife. 2021 Jan 19;10:
pubmed: 33463525
Methods Ecol Evol. 2016 Jan;7(1):80-89
pubmed: 27110344
Philos Trans R Soc Lond B Biol Sci. 2001 Jun 29;356(1410):867-76
pubmed: 11405934
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Mol Biol Evol. 2005 Jul;22(7):1561-8
pubmed: 15814826
Nature. 2016 Oct 12;538(7624):193-200
pubmed: 27734858
J Virol. 2003 Oct;77(20):11296-8
pubmed: 14512579
Mol Biol Evol. 2011 Jan;28(1):523-32
pubmed: 20801907
Philos Trans R Soc Lond B Biol Sci. 2013 Feb 04;368(1614):20120382
pubmed: 23382435
Science. 2009 Jun 19;324(5934):1557-61
pubmed: 19433588
Infect Genet Evol. 2010 Apr;10(3):421-30
pubmed: 19524068
Science. 2021 Feb 12;371(6530):708-712
pubmed: 33419936
Proc Biol Sci. 2014 Jul 7;281(1786):
pubmed: 24850916
Emerg Infect Dis. 2018 Oct;24(10):1795-1805
pubmed: 30226157
Mol Biol Evol. 2007 Mar;24(3):845-52
pubmed: 17218639
Mol Biol Evol. 2015 Jul;32(7):1895-906
pubmed: 25771196
Annu Rev Genomics Hum Genet. 2016 Aug 31;17:193-218
pubmed: 27216777
Virus Evol. 2015 Jan;1(1):
pubmed: 26770819
Bioinformatics. 2002 Oct;18(10):1404-5
pubmed: 12376389
Mol Biol Evol. 1992 Jul;9(4):744-52
pubmed: 1630310
Mol Biol Evol. 2011 Sep;28(9):2443-51
pubmed: 21415025
PLoS Genet. 2008 Dec;4(12):e1000304
pubmed: 19081788
Mol Ecol. 2011 Aug;20(15):3087-101
pubmed: 21740474
PLoS Comput Biol. 2016 Jan 07;12(1):e1004694
pubmed: 26741359
Mol Biol Evol. 2006 Dec;23(12):2271-3
pubmed: 16959870
Cell. 2020 May 28;181(5):997-1003.e9
pubmed: 32359424
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147

Auteurs

Mahan Ghafari (M)

Department of Zoology, University of Oxford, Oxford, United Kingdom.

Louis du Plessis (L)

Department of Zoology, University of Oxford, Oxford, United Kingdom.

Jayna Raghwani (J)

Department of Zoology, University of Oxford, Oxford, United Kingdom.

Samir Bhatt (S)

MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, United Kingdom.

Bo Xu (B)

Department of Earth System Science, Tsinghua University, Beijing, China.

Oliver G Pybus (OG)

Department of Zoology, University of Oxford, Oxford, United Kingdom.

Aris Katzourakis (A)

Department of Zoology, University of Oxford, Oxford, United Kingdom.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH